-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs017201-simon-final-report-2012.pdf
January 01, 2012 - have always “fired” and would not have been able to incorporate the information about
presence or absence
-
digital.ahrq.gov/sites/default/files/docs/citation/asthmacarewithhit_081011comp.pdf
July 01, 2011 - that it had not
anticipated all the contexts in which clinicians might invoke the tool, and in the absence
-
www.ahrq.gov/sites/default/files/2024-01/friese-report.pdf
January 01, 2024 - fragmented care delivery system results in potentially suboptimal care and, perhaps more
important, the absence
-
www.ahrq.gov/hai/tools/ambulatory-surgery/sections/implementation/training-tools/improving-fac-notes.html
May 01, 2017 - is important to identify and recognize the structure of teams, because teamwork cannot occur in the absence
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - In the absence of extensive final health outcomes data, we try to identify the strength of the link between
-
psnet.ahrq.gov/perspective/conversation-cheryl-jones-about-addressing-workplace-violence-and-creating-safer
October 31, 2023 - The absence or lack of system-level supports after an incident has been reported is also a factor contributing
-
psnet.ahrq.gov/perspective/addressing-workplace-violence-and-creating-safer-workplace
October 31, 2023 - The absence or lack of system-level supports after an incident has been reported is also a factor contributing
-
www.ahrq.gov/workingforquality/events/webinar-best-practices-to-improve-community-health.html
November 01, 2016 - We know that health is not the absence of disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - In the absence of these data, the comparative
effectiveness and harms of HSCT for these indications … In the absence of these data the comparative
effectiveness and harms of HSCT for these indications is … transplantation is
able to induce
prolonged and
significant
increases of C-
peptide levels
associated with
absence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder-disposition-160504.pdf
December 08, 2015 - John's Wort, insufficient attention is paid to quality of trials and the
remarkable absence of any trends … Accordingly, the
absence of literature following 2006
reflects the limited data on
comparative effectiveness … Comment Response
continues to assert that medications are necessary for such patients
despite the absence
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/child-maltreatment-primary-care-interventions
March 19, 2024 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Prevention of Child Maltreatment: Primary Care Interventions
March 19, 2024
Recommendations made by the USPSTF are independent of the U.S. go…
-
www.ahrq.gov/sites/default/files/2024-01/gurwitz-report.pdf
January 01, 2024 - Final Progress Report: Enhancing the Safety of Warfarin in the Nursing Home
Project Title: Enhancing the Safety of Warfarin in the Nursing Home
Principal Investigator: Jerry H. Gurwitz, MD
Principal Team Members: Jerry Gurwitz, MD; Terry S. Field, DSc; Jennifer Tjia, MD,
MSCE; Kathleen M. Mazor, EdD; Leslie R. Ha…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
May 29, 2025 - assessment"voiced"concerns"about"the"narrow"
inclusion"and"exclusion"criteria"for"the"original"review,"
and"the"absence"of"studies"that"would"meet"these … An"expert"who"declined"to"participate"in"the"surveillance"assessment"voiced"strong"
concerns"about"the"narrow"criteria/scope"developed"for"the"original"review,"and"the"
absence"of"studies"that"would"meet"these"criteria
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - response
SOE: Low
1 trial of response-guided triple therapy with telaprevir (24 or 48 weeks, based on absence … response
SOE: Low
1 trial of response-guided triple therapy
with telaprevir (24 or 48 weeks, based on
absence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
December 01, 2015 - response
SOE: Low
1 trial of response-guided triple therapy with telaprevir (24 or 48 weeks, based on absence … response
SOE: Low
1 trial of response-guided triple therapy
with telaprevir (24 or 48 weeks, based on
absence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
August 01, 2021 - information as its top sentence and
extracted the relevant fragments, or the tool correctly reported the absence … top sentence and extracted the relevant fragments, or
C-4
the system correctly reported the absence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
June 01, 2012 - standard” (i.e., the best available) reference test is often used to determine true disease presence or absence … diagnostic tests tend to use a separate “gold standard” reference test to determine the true presence or absence
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
March 15, 2007 - NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease … adenoma on medical records database
Randomly selected age- and sex-matched persons from database; absence
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
March 01, 2007 - NSAIDs and risk of colorectal cancer according to presence or absence of
family history of the disease … adenoma on
medical records database
Randomly selected age- and
sex-matched persons
from database; absence
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/pACFPdCoN8fVoddBs-_CLE
November 12, 2019 - between
coping strategies and anxiety in women from
families with familial breast-ovarian cancer in the
absence … Psychological distress in women at risk of
hereditary breast/ovarian or HNPCC cancers
in the absence